Review decisions
Showing 2350 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00247
Product Type: Drug
Control Number: 178006
DIN(s): 02446901
Manufacturer: Merck Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2014-09-15
Issued / Original Publication Date: 2015-11-30
Decision / Authorization Date: 2015-09-30
Updated Date: 2023-03-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00281
Product Type: Drug
Control Number: 177405
DIN(s): 02444844, 02444852, 02461528
Manufacturer: Eli Lilly Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2014-08-29
Issued / Original Publication Date: 2015-10-21
Decision / Authorization Date: 2015-09-01
Updated Date: 2024-07-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00055
Issued / Original Publication Date: 2014-08-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00245
Product Type: Drug
Control Number: 177359
DIN(s): 02444267
Manufacturer: Provensis Ltd.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2014-08-20
Issued / Original Publication Date: 2015-09-18
Decision / Authorization Date: 2015-08-04
Updated Date: 2023-01-11
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00240
Product Type: Drug
Control Number: 177290
DIN(s): 02447401
Manufacturer: Baxalta Canada Corporation
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2014-08-15
Issued / Original Publication Date: 2015-12-03
Decision / Authorization Date: 2015-10-14
Updated Date: 2024-02-20
Summary Safety Review - NEUPOGEN (filgrastim) and NEULASTA (pegfilgrastim) - Capillary Leak Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00056
Issued / Original Publication Date: 2014-07-29
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00246
Product Type: Drug
Control Number: 176820
DIN(s): 02443732, 02443740, 02443759
Manufacturer: Forest Laboratories Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2014-07-29
Issued / Original Publication Date: 2015-09-30
Decision / Authorization Date: 2015-07-16
Updated Date: 2025-08-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00057
Issued / Original Publication Date: 2014-07-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00058
Issued / Original Publication Date: 2014-07-15
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00236
Product Type: Drug
Control Number: 176043
DIN(s): 02443066, 02443074
Manufacturer: Boehringer Ingelheim Canada Ltd./Ltée.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2014-07-09
Issued / Original Publication Date: 2015-08-21
Decision / Authorization Date: 2015-06-25
Updated Date: 2024-08-08